bevacizumab,trifluridine tipiracil
taiho pharma,roche,otsuka
[]
asco #gi23 crc highlights -2 sunlight trial phase iii rct is positive, confirming superiority of lonsurf avastin compared to lonsurf monotherapy with improved os and pfs bevacizumab should be added to lonsurf if used (when no actionable gene) period 
GI Medical Oncologist | @UPMC Hillman CC/@PittTweet | Clinical investigator- Trialist - Colorectal Cancer| EO-CRC| musician-lead guitar | tweets=my own